PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 109 filers reported holding PMV PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,892 | +92.3% | 471,012 | +96.0% | 0.00% | +100.0% |
| Q2 2023 | $1,504 | +23.4% | 240,320 | -6.1% | 0.00% | 0.0% |
| Q1 2023 | $1,219 | -13.7% | 255,922 | +57.7% | 0.00% | 0.0% |
| Q4 2022 | $1,412 | -99.9% | 162,319 | -16.3% | 0.00% | -66.7% |
| Q3 2022 | $2,308,000 | +32.0% | 193,871 | +57.9% | 0.00% | +200.0% |
| Q2 2022 | $1,748,000 | +860.4% | 122,751 | +1309.5% | 0.00% | – |
| Q1 2022 | $182,000 | – | 8,709 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 4,179,416 | $257,076,000 | 54.42% |
| INTERWEST VENTURE MANAGEMENT CO | 6,469,911 | $397,964,000 | 49.71% |
| Octagon Capital Advisors LP | 250,000 | $15,378,000 | 5.33% |
| Boxer Capital, LLC | 2,268,236 | $139,519,000 | 4.48% |
| COMMODORE CAPITAL LP | 125,000 | $7,689,000 | 4.18% |
| Orbimed Advisors | 7,330,423 | $450,894,000 | 3.95% |
| Asymmetry Capital Management, L.P. | 96,595 | $5,942,000 | 2.71% |
| Avoro Capital Advisors LLC | 2,350,267 | $130,536,000 | 2.25% |
| RA Capital Management | 1,710,265 | $105,198,000 | 1.47% |
| HighVista Strategies LLC | 22,654 | $1,393,000 | 0.89% |